Fezolinetant: Postmenopausal Symptoms Management (Non-Hormonal Preparation)
100% Genuine Products, Guaranteed
Safe & Secure Payments, Always
Fast, Secure & Efficient Delivery
Proper Packaging
Indication:
Fezolinetant is indicated for the treatment of moderate to severe vasomotor symptoms due to menopause.
Dosage & Administration:
A single 45 mg Fezolinetant tablet orally once daily with or without food.
While using Fezolinetant, the patient should perform follow-up hepatic laboratory tests monthly for the first 3 months, at 6 months, and 9 months after initiation of therapy or when signs or symptoms suggest liver injury.
Store below 30°C, away from light, and keep out of reach of children.
⚠️Disclaimer:
At ePharma, we’re committed to providing accurate and accessible health information. However, all content is intended for informational purposes only and should not replace medical advice from a qualified physician. Please consult your healthcare provider for personalized guidance. We aim to support, not substitute, the doctor-patient relationship.